Furthermore, Lee et al. [30] investigated whether the PD-L1 gene polymorphisms could predict the clinical outcome of patients with advanced NSCLC after paclitaxel-cisplatin chemotherapy and they found that the rs4143815 CG SNP was significantly associated with a better response under additive model for the G-allele. Here, CD274 is linked to non-small cell lung carcinoma.